1. Niidome, T. and L. Huang, Gene therapy progress and prospects: nonviral vectors. Gene therapy, 2002. 9(24): p. 1647-1652.
2. Wattiaux, R., et al., Endosomes, lysosomes: their implication in gene transfer. Advanced drug delivery reviews, 2000. 41(2): p. 201-208.
3. Ciftci, K. and R.J. Levy, Enhanced plasmid DNA transfection with lysosomotropic agents in cultured fibroblasts. International journal of pharmaceutics, 2001. 218(1): p. 81-92.
4. Laufer, M.K., et al., Return of chloroquine antimalarial efficacy in Malawi. New England Journal of Medicine, 2006. 355(19): p. 1959-1966.
5. de Souza Santos, M., et al., Binding of chloroquine to ionic micelles: Effect of pH and micellar surface charge. Journal of Luminescence, 2014. 147: p. 49-58.
6. Cam, C. and T. Segura, Matrix-based gene delivery for tissue repair. Current opinion in biotechnology, 2013. 24(5): p. 855-863.
7. Rujitanaroj, P.-o., et al., Nanofiber-mediated controlled release of siRNA complexes for long term gene-silencing applications. Biomaterials, 2011. 32(25): p. 5915-5923.
8. Shin, S., et al., Phosphatidylserine immobilization of lentivirus for localized gene transfer. Biomaterials, 2010. 31(15): p. 4353-4359.
9. Yun, Y.H., et al., Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials, 2004. 25(1): p. 147-157.
10. Hatefi, A. and B. Amsden, Biodegradable injectable in situ forming drug delivery systems. Journal of controlled release, 2002. 80(1): p. 9-28.
11. Sailaja, G., et al., Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector specific immune response. Gene therapy, 2002. 9(24): p. 1722.
12. Imani, R., et al., Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells. Colloids and Surfaces B: Biointerfaces, 2016. 147: p. 315-325.
13. Imani, R., S.H. Emami, and S. Faghihi, Synthesis and characterization of an octaarginine functionalized graphene oxide nano-carrier for gene delivery applications. Physical Chemistry Chemical Physics, 2015. 17(9): p. 6328-6339.
14. Imani, R., et al., Polyethylene glycol and octa-arginine dual-functionalized nanographene oxide: an optimization for efficient nucleic acid delivery. Biomaterials science, 2018. 6(6): p. 1636-1650.
15. Leamon, C.P. and J.A. Reddy, Folate-targeted chemotherapy. Advanced drug delivery reviews, 2004. 56(8): p. 1127-1141.
16. Matricardi, P., et al., Recent advances and perspectives on coated alginate microspheres for modified drug delivery. 2008.
17. Orive, G., et al., Biocompatibility of alginate–poly-l-lysine microcapsules for cell therapy. Biomaterials, 2006. 27(20): p. 3691-3700.
18. Imani, R., S.H. Emami, and S. Faghihi, Nano-graphene oxide carboxylation for efficient bioconjugation applications: a quantitative optimization approach. Journal of Nanoparticle Research, 2015. 17(2): p. 1-15.
19. Murdock, R.C., et al., Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicological Sciences, 2008. 101(2): p. 239-253.
20. Huang, P., et al., Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics, 2011. 1: p. 240.
21. Sanz, V., et al., Chloroquine-enhanced gene delivery mediated by carbon nanotubes. Carbon, 2011. 49(15): p. 5348-5358.
22. Chang, T. and S. Prakash, Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms. Molecular Biotechnology, 2001. 17(3): p. 249-260.
23. Paul, A., et al., Injectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair. ACS nano, 2014. 8(8): p. 8050-8062.
24. Zhang, L., et al., Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small, 2010. 6(4): p. 537-544.
25. Hu, C., et al., Fabrication of reduced graphene oxide and sliver nanoparticle hybrids for Raman detection of absorbed folic acid: a potential cancer diagnostic probe. ACS applied materials & interfaces, 2013. 5(11): p. 4760-4768.
26. Wang, J., et al., Delivery of siRNA therapeutics: barriers and carriers. The AAPS journal, 2010. 12(4): p. 492-503.
27. Holliday, D.L. and V. Speirs, Choosing the right cell line for breast cancer research. Breast Cancer Res, 2011. 13(4): p. 215.
28. Cao, X., et al., Folic acid-conjugated graphene oxide as a transporter of chemotherapeutic drug and siRNA for reversal of cancer drug resistance. Journal of nanoparticle research, 2013. 15(10): p. 1-12.
29. Xiang, S., et al., Uptake mechanisms of non-viral gene delivery. Journal of controlled release, 2011.
30. Sabharanjak, S., et al., GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Developmental cell, 2002. 2(4): p. 411-423.
31. Xiang, S., et al., Uptake mechanisms of non-viral gene delivery. Journal of Controlled Release, 2012. 158(3): p. 371-378.
32. Palm-Apergi, C., P. Lönn, and S.F. Dowdy, Do cell-penetrating peptides actually “penetrate” cellular membranes? Molecular Therapy, 2012. 20(4): p. 695-697.
33. Wu, C., et al., Insight into the cellular internalization and cytotoxicity of graphene quantum dots. Advanced healthcare materials, 2013. 2(12): p. 1613-1619.
34. Adler, A.F. and K.W. Leong, Emerging links between surface nanotechnology and endocytosis: impact on nonviral gene delivery. Nano Today, 2010. 5(6): p. 553-569.
35. El-Sayed, A., et al., Octaarginine-and octalysine-modified nanoparticles have different modes of endosomal escape. Journal of Biological Chemistry, 2008. 283(34): p. 23450-23461.
36. Khalil, I.A., et al., High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. Journal of Biological Chemistry, 2006. 281(6): p. 3544-3551.
37. Tu, Z., et al., Combination of Surface Charge and Size Controls the Cellular Uptake of Functionalized Graphene Sheets. Advanced Functional Materials, 2017. 27(33).
38. Fan, C., et al., Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells. Bioorganic & medicinal chemistry, 2006. 14(9): p. 3218-3222.
39. Chen, P.M., Z.J. Gombart, and J.W. Chen, Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: possible implications of lysosomal dysfunction in macular degeneration. Cell Biosci, 2011. 1(1): p. 10-10.
40. Abbasi, S., A. Paul, and S. Prakash, Investigation of siRNA-loaded polyethylenimine-coated human serum albumin nanoparticle complexes for the treatment of breast cancer. Cell biochemistry and biophysics, 2011. 61(2): p. 277-287.
41. Bhattarai, S.R., et al., Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquine. Pharmaceutical research, 2010. 27(12): p. 2556-2568.
42. Thibault, M., et al., Excess polycation mediates efficient chitosan-based gene transfer by promoting lysosomal release of the polyplexes. Biomaterials, 2011. 32(20): p. 4639-4646.
43. Dang, C.V., c-Myc target genes involved in cell growth, apoptosis, and metabolism. Molecular and cellular biology, 1999. 19(1): p. 1-11.
44. Pelengaris, S., M. Khan, and G. Evan, c-MYC: more than just a matter of life and death. Nature Reviews Cancer, 2002. 2(10): p. 764-776.
45. Liao, D. and R. Dickson, c-Myc in breast cancer. Endocrine-related cancer, 2000. 7(3): p. 143-164.
46. Ouyang, W., et al., Artificial cell microcapsule for oral delivery of live bacterial cells for therapy: design, preparation, and in-vitro characterization. J Pharm Pharm Sci, 2004. 7(3): p. 315-24.
47. Goosen, M.F., G.M. O'shea, and A.M. Sun, Microencapsulation of living tissue and cells, 1989, Google Patents.